{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Activities
  • Internal Series
  • On-Demand Activities
  • CE Planning Process
  • About Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
PLEASE CREATE AN ACCOUNT IF:

• You have never attended a Cedars-Sinai CE activity
• OR You are a NEW member of the Cedars-Sinai Medical Staff since August 2023

If you do NOT meet either of the criteria above, please DO NOT CREATE AN ACCOUNT:

• If you do not know which email address is used for your account, please contact the Cedars-Sinai Office of CME.
• Accounts for existing Cedars-Sinai Medical Staff (prior to August 2023) use the primary email on file with the Medical Staff Office.

For ALL USERS: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ATC
  • BSN
  • CCC-SLP
  • CCLS
  • CPhT
  • CRNA
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • EMT
  • EMT-P
  • LCGC
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • NREMT
  • NRP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RDMS
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 39th Annual Case Review with the Experts


Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 39th Annual Case Review with the Experts Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Hotel
Add to Calendar Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 39th Annual Case Review with the Experts 2/19/2027 7:30:00 AM 2/21/2027 2:45:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/nuclearcardiologycme Description: A major national healthcare imperative for noninvasive imaging is for the tests to provide value. Nuclear cardiology and cardiac CT studies provide powerful tools for diagnosis, risk assessment, and guiding management of selected patients with known or suspected cardiac disease. In the current environment, imaging must address the combined considerations of improving outcomes and containing costs. To this end, a... Cedars-Sinai Harvey Morse Conference Center false MM/DD/YYYY


Date & Location
Friday, February 19, 2027, 7:30 AM - Sunday, February 21, 2027, 2:45 PM PT, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience
Specialties - Cardiology, Imaging, Nuclear Medicine
Professions - Nurse (Advanced Practice NP CRNA CNM CNS), Pharmaceutical/Medical Device Representative, Physician Assistant, Radiologic Technologist, Researcher (non-physician), Researcher (physician), Technician

Overview

A major national healthcare imperative for noninvasive imaging is for the tests to provide value. Nuclear cardiology and cardiac CT studies provide powerful tools for diagnosis, risk assessment, and guiding management of selected patients with known or suspected cardiac disease. In the current environment, imaging must address the combined considerations of improving outcomes and containing costs. To this end, advanced cardiac imaging studies must be ordered on the right patients and optimally performed, interpreted, reported, and acted upon by physicians and allied health professionals. Additionally, effective methods to reduce radiation exposure need to be implemented to maximize patient safety. There is a clear need for physicians ordering, performing and interpreting the tests to understand the issues regarding value-based imaging and to optimally implement this understanding. We meet these educational needs through a live activity entitled: Advances in Nuclear Cardiology and Cardiac CT: 39th Annual Case Review with the Experts. The course is designed to meet the current needs of professionals who perform or request nuclear cardiology or cardiac CT. The course covers the use of these modalities across the spectrum of patients routinely seen by cardiologists in typical day-to-day practice and is designed to improve ordering patterns and increase quality in performing, interpreting, reporting and applying the advanced imaging methods. A unique feature of the program is the extensive use case presentations of each subject as a proven effective teaching tool. It also includes multiple sessions with group faculty discussions. There is a focus on incorporating new guidelines in practice and the latest evidence from clinical trials and registry findings.


Objectives
  1. Identify up to date evidence regarding the information provided by tests, the appropriate use of testing an how the tests affect outcomes an costs in coronary and noncoronary heart and aortic disease
  2. Recognize the implications of societal chest pain and prevention guidelines on the use of noninvasive testing
  3. Explain how new approaches to functional assessment, such as coronary flow reserve, noninvasive fractional flow reserve and plaque measurements increase test information
  4. Improve image interpretation and recognition of image artifacts
  5. Recognize the implications of societal chest pain and prevention guidelines on the use of noninvasive testing
  6. Recognize strategies for reducing patient radiation and contrast exposure
  7. Create optimal reports that integrate test findings and provide guidance for patient management
  8. Learn how AI approaches for test interpretations are changing the field
  9. Use criteria and evidence based strategies to reduce inappropriate testing
  10. Identify the latest information regarding how test findings should be used to guide patient management decisions

Registration

Full Conference Registration Options

• Physicians (In-person) - $750.00

• All Other Healthcare Providers (In-person) - $400.00

• Residents/Fellows (In-person) - $300.00

Technologist Registration Options

• Technologists (In Person) - Nuclear Session - All 3 Days - $300.00

• Technologists (In Person)-Nuclear Session-Friday and Saturday Only - $300.00

• Technologists (In Person)-Nuclear Session- Saturday and Sunday Only - $300.00


Accreditation

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 20.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

MAINTENANCE OF CERTIFICATION (MOC) FOR PHYSICIANS: Successful completion of some CME activities, which includes participation in the evaluation component if required for the activity, may enable the participant to earn MOC points. As the CME activity provider, it is Cedars-Sinai’s responsibility to submit participant completion information to the ACCME for the purpose of granting earned MOC credit, provided the learner has completed the “Credit Reporting” steps indicated above in advance of the activity. If offered for this CME activity, MOC type and points that may be earned are indicated below.

American Board of Internal Medicine (ABIM) Part II MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (20.00 hours), ABIM MOC Part 2 (20.00 hours), Non-Physician AMA Attendance (20.00 hours)


Keywords: LIVEABIM2AMAMOC

Cedars-Sinai has negotiated special rates at a variety of hotels at or near the conference venue, offering options at multiple price points to accommodate different preferences and budgets.

To view local hotels and access more details, please click the link below: Hotel List
When reaching out, be sure to mention Cedars-Sinai and its negotiated hotel rates.


Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Faculty Photos
Daniel S. Berman, MD
Cedars-Sinai
Course Director, Faculty
Nothing to disclose
Faculty Photos
Panithaya Chareonthaitawee, MD
Mayo Clinic
Course Director, Faculty
Other: Royalties-UpToDate|Other: Expert Roundtable-GE Healthcare|Consultant-Cardiovascular Clinical Sciences|Consultant-IBA (Relationship has ended)|Other: Advisory Board-Synektik
Damini Dey, PhD
Cedars-Sinai Medical Center
Course Director, Faculty
Nothing to disclose
Faculty Photos
Jonathon Leipsic, MD
University of British Columbia
Course Director, Faculty
Consultant-Heartflow|Consultant-Circle|Speaker-GE Healthcare Bio-Sciences (Relationship has ended)|Other: Core lab-Edwards Lifesciences LLC|Consultant-Arineta
Faculty Photos
Robert Miller, MD
University of Calgary
Canada
Course Director, Faculty
Consultant-Bayer Corporation (Relationship has ended)
Faculty Photos
Alan Rozanski, MD
Mount Sinai Morningside Hospital
Course Director, Faculty
Nothing to disclose
Faculty Photos
Piotr Slomka, PhD, FACC
Cedars-Sinai Medical Center
Course Director, Faculty
Consultant-Synektik|Consultant-Novo Nordisk|PrincipalNamedInvestigator-Siemens AG (Relationship has ended)
Faculty Photos
Stephan Achenbach, MD
University of Erlangen - Germany
Germany
Faculty
Mouaz H. Al-Mallah, MD
Houston Methodist
Faculty
Faculty Photos
Timothy M. Bateman, MD
Saint-Luke's Health System, University of Missouri, Kansas City School of Medicine
Faculty
Faculty Photos
Matthew Budoff, MD
The Lundquist Institute
Faculty
Speaker-Regeneron|Speaker-Novo Nordisk|Independent ContractorResearcher-Lilly
Faculty Photos
Marcelo Di Carli, MD
Brigham and Women's Hospital
Faculty
Faculty Photos
Sharmila Dorbala, MD
Brigham and Women's Hospital
Faculty
Faculty Photos
John Friedman, MD
Cedars-Sinai Medical Center
Faculty
Faculty Photos
Sean W. Hayes, MD
Cedars-Sinai Medical Center
Faculty
Waseem Hijazi, MD
University of Calgary
Canada
Faculty
Waseem Hijazi, MD
Faculty
Faculty Photos
Michelle Kittleson, MD, PhD
Cedars-Sinai
Faculty
Nothing to disclose
Faculty Photos
Alan C. Kwan, MD
Cedars Sinai
Faculty
Nothing to disclose
Faculty Photos
Jamshid Maddahi, MD
UCLA School of Medicine
Faculty
Faculty Photos
David Newby, MD
The University of Edinburgh
United Kingdom
Faculty
Consultant-GlaxoSmithKline|Consultant-Bayer Corporation|Consultant-Life Molecular Imaging
Yader Sandoval, MD
Minneapolis Heart Institute, Abbott Northwestern Hospital
Faculty
Faculty Photos
Leslee J Shaw, PhD
Icahn School of Medicine at Mount Sinai
Faculty
Speaker-Heartflow|Speaker-Elucid (Relationship has ended)
Faculty Photos
Leandro Slipczuk Bustamante, MD, PhD
Montefiore
Faculty
Faculty Photos
Janet Wei, MD, FACC
Cedars-Sinai
Faculty
Rebekah H. Park, MPH
Cedars-Sinai Medical Center
Planner
Nothing to disclose

Friday, February 19, 2027
Registration Check-In and Exhibits
7:30AM - 7:50AM
Course Overview and Objectives: Why Have this Program?
7:50AM - 8:00AM
Daniel S. Berman, MD
 
SESSION 1: SPECT AND PET MPI: GETTING THE ANSWER RIGHT

Daniel S. Berman, MD, FACC, Presiding
Nuclear Cardiology in 2027: What is Changing and What Should We Be Doing Differently?
8:00AM - 8:20AM
Marcelo Di Carli, MD

AI in SPECT and PET: What Can It Do for Us?
8:20AM - 8:40AM
Piotr Slomka, PhD, FACC

Case Reviews: AI-Assisted SPECT/PET Interpretation: Cases Where AI Helps and Where It Doesn’t
8:40AM - 9:00AM
Robert Miller, MD

Case Reviews: The Scan Looks Abnormal, but Is It? Avoiding the Most Important SPECT/PET Pitfalls
9:00AM - 9:30AM
Sean W. Hayes, MD

Optimizing SPECT When I Don’t have PET
9:30AM - 9:45AM
Timothy M. Bateman, MD

Panel Discussion/Q&A: The Difficult MPI Study - What would you do?
9:45AM - 10:05AM
Sean W. Hayes, MD
Daniel S. Berman, MD (Moderator)
Piotr Slomka, PhD, FACC
Robert Miller, MD
Timothy M. Bateman, MD
Marcelo Di Carli, MD

Break/Exhibits/Break-Out Session #1
10:05AM - 10:25AM

 
SESSION 2: BEYOND PERFUSION: GETTING MORE FROM EVERY STUDY

Daniel S. Berman, MD, FACC, Presiding
CAD is Changing: Are We Still Testing the Right Patients in the Right Way?
10:25AM - 10:45AM
Alan Rozanski, MD
Pharmacologic Stress: Pearls about what you need to know
10:45AM - 11:05AM
Sean W. Hayes, MD
The Forgotten Vital Sign: Exercise Capacity and Functional Assessment
11:05AM - 11:25AM
Alan Rozanski, MD
CAC + Perfusion: How and Why Anatomy Is Part of Nuclear Cardiology
11:25AM - 11:40AM
Mouaz H. Al-Mallah, MD
CAC, AI Analysis of Epicardial Fat, Chamber Volumes and Body Composition: The Information Hiding in your Nuclear Study
11:40AM - 12:00PM
Piotr Slomka, PhD, FACC
Panel Discussion/Q&A: What Information Should be in the Modern MPI Report?
12:00PM - 12:20PM
Sean W. Hayes, MD
Daniel S. Berman, MD (Moderator)
Alan Rozanski, MD
Piotr Slomka, PhD, FACC
Mouaz H. Al-Mallah, MD
Lunch and Exhibits
12:20PM - 1:05PM


12:35 PM -1:00 PM
Optional CSMC Cardiac Imaging Laboratories Site Visit (No CME/CE credit)
Mina Sadeghi


 
SESSION 3: MYOCARDIAL BLOOD FLOW: FROM NUMBERS TO CLINICAL DECISIONS

Daniel S. Berman, MD, FACC, Presiding
PET MBF/MFR: How I Make Sure the Numbers are Real
1:05PM - 1:20PM
Timothy M. Bateman, MD
Normal Perfusion, Abnormal Flow: What Do I Tell the Clinician?
1:20PM - 1:35PM
Marcelo Di Carli, MD
SPECT: Flow: Ready for Clinical Practice?
1:35PM - 1:50PM
Piotr Slomka, PhD, FACC
Quantitative Stress CMR: Is It Ready to Compete with PET?
1:50PM - 2:05PM
Alan C. Kwan, MD
PET or SPECT: Choosing the Right Test for the Right Patient
2:05PM - 2:20PM
Timothy M. Bateman, MD
Microvascular Disease: What PET and CMR Can and Cannot Tell Us
2:20PM - 2:35PM
Janet Wei, MD, FACC
Panel Discussion/Q&A: MFR Is 1.7 – What Do You Recommend?
2:35PM - 2:55PM
Alan C. Kwan, MD
Janet Wei, MD, FACC
Daniel S. Berman, MD (Moderator)
Piotr Slomka, PhD, FACC
Timothy M. Bateman, MD
Marcelo Di Carli, MD
Break/Exhibits/Break-Out Session #3
2:55PM - 3:15PM
 
SESSION 4: FLURPIRIDAZ: A NEW ERA FOR PET MPI

Daniel S. Berman, MD, FACC, Presiding
Flurpiridaz: Why This Tracer Changes PET Perfusion Imaging
3:15PM - 3:35PM
Jamshid Maddahi, MD
Starting a Flurpiridaz Program: What You Need to Know
3:35PM - 3:50PM
Timothy M. Bateman, MD
Flow, Perfusion and Subendocardial Ischemia with Flurpiridaz
3:50PM - 4:05PM
Piotr Slomka, PhD, FACC
Exercise Flurpiridaz: What is the Protocol of Choice?
4:05PM - 4:25PM
Panithaya Chareonthaitawee, MD
Case Reviews: Challenges in Interpretation
4:25PM - 4:50PM
Mouaz H. Al-Mallah, MD

Panel Discussion/Q&A: Will Flurpiridaz Change Nuclear Cardiology?
4:50PM - 5:10PM
Daniel S. Berman, MD (Moderator)
Piotr Slomka, PhD, FACC
Panithaya Chareonthaitawee, MD
Timothy M. Bateman, MD
Jamshid Maddahi, MD
Mouaz H. Al-Mallah, MD
Adjourn
5:10PM - 5:15PM
Saturday, February 20, 2027
Registration Check-In and Exhibits
7:30AM - 8:00AM
 
SESSION 5: STUMP THE EXPERTS

John D. Friedman, MD, Presiding/Presenting
Challenging PET and SPECT Cases
8:00AM - 9:00AM
Daniel S. Berman, MD
Timothy M. Bateman, MD
Marcelo Di Carli, MD
Jamshid Maddahi, MD
 
SESSION 6: INFLAMMATORY HEART DISEASE: PET OR MRI?

Daniel S. Berman, MD, FACC, Presiding
Cardiac Sarcoidosis: What PET Does Best
9:00AM - 9:15AM
Sharmila Dorbala, MD
Cardiac Sarcoidosis and Myocarditis: What CMR Does Best
9:15AM - 9:30AM
Alan C. Kwan, MD
FDG PET for Sarcoidosis: How to Avoid a Nondiagnostic Study
9:30AM - 9:45AM
Panithaya Chareonthaitawee, MD
Quantifying Inflammation: Does it Improve Interpretation?
9:45AM - 10:00AM
Robert Miller, MD
Viability in 2027: Does it Still Matter? PET vs CMR
10:00AM - 10:15AM
Mouaz H. Al-Mallah, MD
Panel Discussion/Q&A: PET vs CMR – Which Test Would You Order?
10:15AM - 10:30AM
Alan C. Kwan, MD
Daniel S. Berman, MD (Moderator)
Robert Miller, MD
Panithaya Chareonthaitawee, MD
Sharmila Dorbala, MD
Mouaz H. Al-Mallah, MD
Break/Exhibits/Break-Out Session #4
10:30AM - 10:50AM

 
SESSION 7: CARDIAC AMYLOIDOSIS: A FIELD BEING TRANSFORMED

Daniel S. Berman, MD, FACC, Presiding
Amyloid Therapy in 2027: Why Earlier Diagnosis Matters More Than Ever
10:50AM - 11:05AM
Michelle Kittleson, MD, PhD
What Should I Suspect Amyloidosis and What Test Should I Order First?
11:05AM - 11:20AM
Sharmila Dorbala, MD
PYP Imaging: The 10 Things You Need to Get Right
11:20AM - 11:35AM
Panithaya Chareonthaitawee, MD
CMR in Amyloidosis: Strengths and Limitations
11:35AM - 11:50AM
Alan C. Kwan, MD
Amyloid PET: Evuzamitide (I-124) a Game Change for Monitoring Therapy in ATTR/AL
11:50AM - 12:05PM
Sharmila Dorbala, MD
Can We Make PYP Quantitative, and Should We?
12:05PM - 12:20PM
Robert Miller, MD
Panel Discussion/Q&A: The Amyloid Patient in 2027- PYP, PET, CMR, Biopsy
12:20PM - 12:40PM
Michelle Kittleson, MD, PhD
Alan C. Kwan, MD
Daniel S. Berman, MD (Moderator)
Robert Miller, MD
Panithaya Chareonthaitawee, MD
Sharmila Dorbala, MD

Lunch and Exhibits
12:40PM - 1:25PM

1:00 PM - 1:20 PM
Optional CSMC Cardiac Imaging Laboratories Site Visit (No CME/CE credit)
Mina Sadeghi


 
SESSION 8: CARDIAC CT: OVERVIEW I

Jonathon Leipsic, MD, FACC, Presiding
Coronary CTA: The Road to Class I and Beyond
1:25PM - 1:40PM
Stephan Achenbach, MD
Case Review: Coronary CTA Interpretation and Reporting
1:40PM - 2:10PM
Waseem Hijazi, MD
Case Review: When CCTA Fail: Calcium, Small Stents, Motion and More Real-World Problem
2:10PM - 2:30PM
Matthew Budoff, MD
Coronary CTA in Symptomatic Patient: How I Use it?
2:30PM - 2:50PM
David Newby, MD
Primary Prevention: The Primacy of CAC
2:50PM - 3:05PM
Matthew Budoff, MD
Primary Prevention: Will Coronary CTA Become the Test of Choice
3:05PM - 3:20PM
David Newby, MD
Women with Chest Pain: Should our Imaging Strategy Be Different?
3:20PM - 3:35PM
Leslee J Shaw, PhD
Panel Discussion/Q&A: CCTA in 2027—Who Should Get It and How Should It Change Management?
3:35PM - 3:55PM
Waseem Hijazi, MD
Daniel S. Berman, MD
Jonathon Leipsic, MD (Moderator)
Matthew Budoff, MD
David Newby, MD
Leslee J Shaw, PhD
Break/Exhibits/Break-Out Session #6
3:55PM - 4:15PM
 
SESSION 9: CHOOSING THE RIGHT TEST

Jonathon Leipsic, MD, FACC, Presiding
DEBATE: CCTA Will Replace Stress Testing for Evaluation of CAD (PRO)
4:15PM - 4:25PM
Jonathon Leipsic, MD

DEBATE: CCTA Will Replace Stress Testing for Evaluation of CAD (CON)
4:25PM - 4:35PM
Marcelo Di Carli, MD

Case Presentations: Which Test Would You Recommend
4:45PM - 5:15PM
Waseem Hijazi, MD
Daniel S. Berman, MD
Jonathon Leipsic, MD
Timothy M. Bateman, MD
Matthew Budoff, MD
David Newby, MD
Mouaz H. Al-Mallah, MD

Recommend: 
• Atypical chest pain, multiple risk factors, CAC 2000
• Atypical chest pain, normal PET perfusion, MFR 1.6, CAC 100
• Asymptomatic with multiple risk factors
• Asymptomatic with deep myocardial bridge on CCTA

Presenter: Waseem Hijazi

Adjourn
5:15PM - 5:20PM
Sunday, February 21, 2027
Registration Check-In and Exhibits
7:30AM - 8:00AM

 
SESSION 10: CCTA BEYOND STENOSIS: PLAQUE AND PHYSIOLOGY

Daniel S. Berman, MD, FACC, Presiding
AI Coronary Plaque Quantification: State of the Art
8:00AM - 8:20AM
Damini Dey, PhD
Quantitative CCTA Plaque: From Measurement to the Clinical Report
8:20AM - 8:35AM
Daniel S. Berman, MD
FFRCT and AI Ischemia in Guiding Patient Management
8:35AM - 8:55AM
Jonathon Leipsic, MD
Pericoronary Fat for Inflammation
8:55AM - 9:10AM
Leandro Slipczuk Bustamante, MD, PhD
Photon Counting CT: A Whole New Ball Game?
9:10AM - 9:25AM
David Newby, MD
Cases from My Daily Practice: How I Use Plaque and Physiology to Guide Patient Management
9:25AM - 9:40AM
Leandro Slipczuk Bustamante, MD, PhD
Panel Discussion/Q&A: Plaque and Physiology: Where do they Really Change Practice
9:40AM - 10:00AM
Daniel S. Berman, MD (Moderator)
Jonathon Leipsic, MD
Damini Dey, PhD
David Newby, MD
Leandro Slipczuk Bustamante, MD, PhD
Break/Exhibits/Break-Out Session #7
10:00AM - 10:20AM

 
SESSION 11: Battle of the CCTA Experts: Read It If You Can!

Jonathon Leipsic, MD, FACC, Presiding
Rapid-Fire Unknown CCTA Cases from Clinical Practice
10:20AM - 11:20AM
John Friedman, MD
Waseem Hijazi, MD
Matthew Budoff, MD
David Newby, MD


Team 1: Newby, Friedman 

Vs 

Team 2: Budoff, Hijazi


 
SESSION 12: CARDIAC CT BEFORE CATH: CAD AND STRUCTURAL HEART DISEASE

Jonathon Leipsic, MD, FACC, Presiding
DEBATE: CCTA Will Ultimately Replace Invasive Coronary Angiography (PRO)
11:20AM - 11:30AM
David Newby, MD
DEBATE: CCTA Will Ultimately Replace Invasive Coronary Angiography (CON)
11:30AM - 11:40AM
Yader Sandoval, MD
Rebuttal
11:40AM - 11:50AM
Pre-PCI CCTA: Changing practice for the Interventionalist Concepts and Case Reviews
11:50AM - 12:20PM
Yader Sandoval, MD
CT Has Changed Structural Heart Intervention: What Every Cardiologist Should Know
12:20PM - 12:40PM
Jonathon Leipsic, MD
Panel Discussion/Q&A: Will CCTA Become Routine Prior to Cath?
12:40PM - 1:00PM
Jonathon Leipsic, MD (Moderator)
David Newby, MD
Yader Sandoval, MD

Boxed-Lunch Pick-Up
1:00PM - 1:15PM
 
SESSION 13: HAVE FUN AND WRAP IT UP

Daniel S. Berman, MD, FACC, Presiding
Cardiac Imaging Jeopardy: Nuclear, CT and CMR
1:15PM - 2:15PM
Robert Miller, MD

Attendee Participation. Prize awarded to winner!
Putting it All Together: Choosing the Right Test for the Right Patient
2:15PM - 2:35PM
Daniel S. Berman, MD
Adjourn
2:35PM - 2:40PM


CE Disclosure Form  | CE Application  | Privacy  |  Cedars-Sinai CME Homepage

Contact Us: [email protected]

        

© 2026 Cedars-Sinai Health Sciences University. All Rights Reserved. A 501(c)(3) non-profit organization.